Ching Man Choi

Ching Man Choi is the Chief Executive Officer at THERAtRAME. Prior to joining THERAtRAME, Ching Man Choi held the role of Business Development / Investor Relations Manager at BONE THERAPEUTICS S.A. and Financial & Business Analyst at Hospidex. Ching Man Choi also has experience as an Associate Scientist at VIB and as a panel coordinator at Vlerick Business School. Ching Man Choi holds a Master's degree in Financial Management from Vlerick Business School, a PhD Fellow in Human Genetics- Neuroscience from KU Leuven, and a Master's degree in Biochemistry from the University of Antwerp.